New insider activity at Impact BioMedical, Inc. ( (IBO) ) has taken place on March 29, 2025.
Significant shareholder Document Security Systems Inc. has divested a substantial portion of its holdings in Impact BioMedical, Inc., selling 605,620 shares. This transaction is valued at $1,950,231, marking a notable shift in the company’s stock ownership landscape.
Recent Updates on IBO stock
Impact BioMedical, Inc. has recently appointed Mr. Chan Heng Fai Ambrose as a Director, bringing over forty-five years of experience in financial and equity investment. His expertise in restructuring and leadership in publicly listed companies is anticipated to enhance the company’s strategic direction and governance. This development may influence market sentiment and investor confidence, potentially impacting the stock’s performance. Despite a year-to-date price performance decline of 56.88%, the technical sentiment consensus remains a strong buy, suggesting optimism about future prospects.
More about Impact BioMedical, Inc.
YTD Price Performance: 48.05%
Average Trading Volume: 3,140,132
Technical Sentiment Signal: Strong Sell